Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study
NCT04722094 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 147
Last updated 2021-02-24
Summary
Psoriasis is a chronic inflammatory disease with a multi-factorial etiology which affects the epidermis and dermis. It affects around 1-3% of the general population and its most frequent form is plaque psoriasis (around 80-90% of the overall psoriasis cases). Psoriasis severity and extension are usually measured through 2 scores: Psoriasis Area Severity Index (PASI) and Body Surface Area (BSA). Periodontitis is a chronic inflammatory disease mediated by the biofilm and with a multi-factorial etiology. Its manifestation entails the destruction of the periodontal tissues surrounding the teeth; the final stage of disease is characterised by tooth loss. Periodontitis severity and extension are usually evaluated through surrogate variables such as: BoP (Bleeding on Probing), PPD (Probing Pocket Depth) e REC (Recession). Both diseases present overlapping genetic and pathophysiologic features, as well as common risk factors (e.g. genetic polymorphisms, smoking habit, obesity, diabetes etc.).
miRNAs are small non-coding molecules involved in the regulation of various biologic processes thanks to their interaction with mRNAs. Active inflammatory processes either in the oral cavity or at a systemic level tend to alter the concentration of salivary miRNAs. No study so far has ever profiled the levels of specific salivary miRNAs in patients with psoriasis and periodontitis.
Some case-control studies highlighted a higher prevalence of periodontitis in patients with psoriasis when compared to healthy controls. Nonetheless, epidemiological data regarding periodontitis prevalence in patients with psoriasis are lacking; moreover, few data are available regarding the relationship between the severity of psoriasis and the severity of periodontitis, together with the effect of common risk factors (e.g. diet, obesity, physical activity, sleep quality etc.).
Conditions
- Psoriasis
- Plaque Psoriasis
- Periodontal Diseases
- Periodontitis
Interventions
- DIAGNOSTIC_TEST
-
Full periodontal chart
A full periodontal chart will be carried out including all biometric periodontal variables: Probing Pocket Depth (PPD), Bleeding on Probing (BoP), presence of Plaque, recession (REC), Full Mouth Plaque Score (FMPS), Full Mouth Bleeding Score (FMBS), presence of furcation and mobility. Periodontal status, as assessed by the periodontal chart, will be evaluated following the New Classification of Periodontal and Peri implant diseases.
- OTHER
-
Saliva sampling
Saliva samples for miRNAs detection will be taken before starting the visit.
Sponsors & Collaborators
-
University of Siena
lead OTHER
Principal Investigators
-
Nicola Discepoli, DDS, MsC, PhD · University of Siena
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-25
- Primary Completion
- 2021-06-25
- Completion
- 2021-08-25
Countries
- Italy
Study Locations
More Related Trials
-
Prevalence and Progression of Periodontitis in Ankylosing Spondylitis
NCT01750528 ·Status: COMPLETED
-
The Effect of Periodontal Treatment on Psoriasis
NCT03939936 ·Status: COMPLETED ·Phase: NA
-
Periodontal Health Status in Patients with Systemic Sclerosis
NCT05215431 ·Status: RECRUITING ·Phase: NA
-
Pathogenesis of Periodontal Disease in Individuals With Psoriasis
NCT07158125 ·Status: NOT_YET_RECRUITING
-
LONGITUDINAL FOLLOW-UP STUDY TO DETERMINE THE PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED PATIENTS
NCT07167771 ·Status: NOT_YET_RECRUITING
-
The Prevalence of Gingival Pigmentation Among a Sample of Adult Egyptian Population.
NCT05453890 ·Status: COMPLETED
-
The Effect of Non-Surgical Periodontal Therapy on Rheumatoid Arthritis
NCT06245265 ·Status: COMPLETED ·Phase: NA
-
Periodontal Status in Patients With Chronic Skin Diseases
NCT06073613 ·Status: COMPLETED
-
Periodontal Pathogens and Atherom Plaque The Number of Mitochondrial DNA Copies
NCT07165054 ·Status: COMPLETED
-
Periodontal Disease and Circulatory Microbial Components
NCT01154855 ·Status: COMPLETED
-
Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease
NCT06528522 ·Status: NOT_YET_RECRUITING
-
Prevalence Of Periodontitis Stage III & IV
NCT03779763 ·Status: COMPLETED
-
Rheumatoid Arthritis and Treatment of Periodontitis: a Randomized Clinical Trial.
NCT05271890 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic
NCT02220751 ·Status: COMPLETED ·Phase: PHASE3
-
Staging and Grading of Periodontitis: Five Years Later
NCT06188884 ·Status: NOT_YET_RECRUITING
-
PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED SUBJECTS
NCT06047132 ·Status: COMPLETED
-
Periodontitis, Sleep Quality and Fatigue
NCT05622019 ·Status: COMPLETED
-
GCF PLAP-1, Sclerostin and TNF-α Levels in Periodontitis
NCT05656989 ·Status: COMPLETED
-
Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients
NCT06408454 ·Status: COMPLETED
-
Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases
NCT02503046 ·Status: COMPLETED
-
Serological Evaluation of 77A/G and 11A/12A Gene of MMP-13 in Periodontitis Affected and Healthy Individuals
NCT02423304 ·Status: UNKNOWN
-
Periodontitis and Inflammation: Study on Biological Samples
NCT06012019 ·Status: RECRUITING
-
Treatment of Periodontal Disease in Systemic Lupus Erythematosus
NCT04046172 ·Status: UNKNOWN ·Phase: NA
-
Estimation of Pentrexin-3 Levels in GCF and Saliva of Patients With Periodontal Disease
NCT03128502 ·Status: COMPLETED
-
Influence of Environmental Factors on the Efficacy of Non-surgical Periodontal Treatment. A Pre-post Quasi-experimental Study
NCT04769622 ·Status: UNKNOWN